← Eichor
Study identifier: NCT06812611 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of High Intensity Laser Therapy in Muscle Injuries

Condition: Muscle Tear  ·  Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

PhaseNA
Planned participants24
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

Muscle injuries are frequent traumatic events in daily life, particularly during sports. In sports, their incidence varies from 10% to 55% of total injuries. According to the Mueller Wohlfart classification, muscle injuries are classified into direct traumatic injuries (contusion-laceration) and indirect traumatic injuries, which are further divided into non-structural injuries (grade I and II) and structural injuries. Structural lesions are further divided into partial muscle lesions (grade III): 3 A, minor partial lesion, i.e. lesion of one or more primary bundles with a secondary bundle; 3 B, moderate partial lesion, i.e. lesion of at least one secondary bundle and with a rupture area \< 50% of the muscle surface; and (sub)total muscle injury (grade IV).

This description comes directly from the study's public registry record.

Talk to the study team

Angela Notarnicola, M.D.Ph.D.  ·  0805592938  ·  angelanotarnicola@yahoo.it

Always discuss trial participation with your own doctor first.

Locations (1)

Policlinico di BariBari, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06812611